Try our beta test site
1 study found for:    16061871 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: gefitinib

Study has passed its completion date and status has not been verified in more than two years.